- US-listed companies
- RESMED INC
RESMED INCRMD
Market cap
$35B
P/E ratio
Jun 30, 2012 | Jun 30, 2013 | Jun 30, 2014 | Jun 30, 2015 | Jun 30, 2016 | Jun 30, 2017 | Jun 30, 2018 | Jun 30, 2019 | Jun 30, 2020 | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | |
Sleep And Respiratory | - | - | - | - | - | - | - | - | 2,602 | 2,823 | 3,177 | 3,725 |
Software as a Service | - | - | - | - | - | - | - | - | - | - | - | 498 |
Net revenue | 1,369 | 1,514 | 1,555 | 1,679 | 1,839 | 2,067 | 2,340 | 2,607 | 2,957 | 3,197 | 3,578 | 4,223 |
Sleep And Respiratory | - | - | - | - | - | - | - | - | 1,068 | 1,177 | 1,365 | 1,663 |
Software as a Service | - | - | - | - | - | - | - | - | - | - | - | 174 |
Cost of sales (exclusive of amortization shown separately below) | - | - | - | - | - | - | - | - | 1,190 | 1,313 | 1,514 | 1,837 |
Sleep And Respiratory | - | - | - | - | - | - | - | - | 9 | 5 | 4 | 5 |
Software as a Service | - | - | - | - | - | - | - | - | - | - | - | 25 |
Amortization of Intangible Assets | 14 | - | - | - | - | - | - | - | 50 | 45 | 40 | 30 |
Total cost of sales | - | - | - | - | - | - | - | 1,070 | 1,239 | 1,358 | 1,554 | 1,867 |
Gross profit | 821 | 941 | 990 | 1,011 | 1,066 | 1,202 | 1,362 | 1,537 | 1,718 | 1,839 | 2,024 | 2,356 |
Selling, general, and administrative | 402 | 431 | 450 | 479 | 488 | 554 | 600 | 645 | 677 | 670 | 739 | 874 |
Research and development | 110 | 120 | 118 | 115 | 119 | 144 | 155 | 181 | 202 | 225 | 254 | 288 |
Amortization of acquired intangible assets | - | - | - | - | - | - | - | - | - | - | - | 42 |
Restructuring expenses (note 18) | - | - | - | - | - | - | - | - | - | - | - | 9 |
Acquisition related expenses | - | - | - | - | - | 10 | - | 6 | - | - | - | 11 |
Total operating expenses | 526 | 586 | 585 | 602 | 638 | 776 | 820 | 957 | 908 | 935 | 1,024 | 1,224 |
Income from operations | 294 | 355 | 405 | 409 | 429 | 426 | 542 | 579 | 810 | 904 | 1,000 | 1,132 |
Interest (expense) income, net | - | - | - | - | - | - | - | - | - | - | -22 | -47 |
Income (Loss) from Equity Method Investments | - | - | - | - | - | - | - | -16 | -25 | -11 | -8 | -7 |
Equity Securities, FV-NI, Gain (Loss) | - | - | - | - | - | - | - | - | - | - | -12 | 10 |
Gain on insurance recoveries | - | - | - | - | - | - | - | - | - | - | - | 20 |
Other, net | 8 | -2 | 1 | 6 | 5 | 4 | -9 | -11 | -12 | 15 | 3 | -6 |
Total other income (loss), net | 38 | 30 | 26 | 27 | 11 | -7 | -21 | -60 | -77 | -20 | -40 | -30 |
Income before income taxes | 332 | 385 | 431 | 436 | 440 | 419 | 521 | 519 | 733 | 884 | 960 | 1,102 |
Income taxes (note 12) | 77 | 78 | 86 | 83 | 87 | 76 | 206 | 114 | 111 | 409 | 181 | 204 |
Net income | 255 | 307 | 345 | 353 | 352 | 342 | 316 | 405 | 622 | 475 | 779 | 898 |
Earnings Per Share, Basic | 1.75 | 2.15 | 2.44 | 2.51 | 2.51 | 2.42 | 2.21 | 2.83 | 4.31 | 3.27 | 5.34 | 6.12 |
Earnings Per Share, Diluted | 1.71 | 2.1 | 2.39 | 2.47 | 2.49 | 2.4 | 2.19 | 2.8 | 4.27 | 3.24 | 5.3 | 6.09 |
Common Stock, Dividends, Per Share, Declared | - | 0.68 | 1 | 1.12 | 1.2 | 1.32 | 1.4 | 1.48 | 1.56 | 1.56 | 1.68 | 1.76 |